Delivery Order SPE2DB22D2211-SPE2DB24FMXK5
- Not listed
- The federal contract award is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,647.94 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a...
- This federal contract award is for the delivery of ondansetron ODT 8 mg tablets to the Medical Supply Chain, a part of the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,390.64 and was awarded on December 28, 2023, with a completion date of December 29, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,022.65 and an ultimate completion date of December 19, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
- This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $6,905.01 and is a Firm Fixed Price Delivery Order with a completion date of May 30, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and was awarded on May 29, 2025. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,154.60 for the supply of Ondansetron ODT 8 mg tablets. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price agreement. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a completion date of December 9, 2024. The contract has a ceiling value of $8,884.29 and is a firm fixed-price delivery order. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp has a...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,721.24 and an ultimate completion date of May 19, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award is for the delivery of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price of $4,338.75 and has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $6,699.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of 4,564,128,973 units of Ondansetron ODT 8 mg Tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, is the prime contractor on an indefinite delivery...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMXK5Delivery Order
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,274.24 and runs through March 1, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/29/24 |